Top tips for growing a thriving primary care network

31 January 2019

By Helen Northall

The NHS’s 10-year plan may be billed as long term, but policy makers expect general practices to leap into action to form primary care networks (PCNs). According to the NHS Long Term Plan, practices have until July to get into groups. 

Ultimately GPs might well welcome the voice that the networks will give general practice and the status they gain as the building blocks for integrated care systems. Those systems, after all, appear set to be the geographical footprint for key decision making  in the near future.

However, currently just 30% of practices are members of PCNs – and many existing networks don’t meet the exact criteria set out for them in the ten year plan, either because they’re bigger than the 30,000-50,000 specified in the plan or because they fail to share neat boundaries with other community services or with social care.

For most practices therefore, even those already in some sort of PCN arrangement, pause for thought would be useful. Time may be a luxury the plan does not afford them but they should take a deep breath and think clearly about how they will set about building and nurturing new relationships.

With practice incomes likely to be increasingly reliant on contracts secured by their PCNs, there is a financial incentive for making them work – but also for getting them right first time.

Our work helping to join up primary care services suggests ten things GPs and existing PCNs should do as they respond to the government’s urgent call to arms.

  1. Most importantly (and despite the need for speed), take the time to agree a shared vision that  practices – and other network partners – feel they can both sign up to and help deliver.
  2. Don’t focus too much on form or structure at the start. The form, for example a limited company – should follow the vision or goals and enable the network to achieve its agreed purpose. 
  3. Spend time on relationships between member organisations and work on building trust.
  4. Communicate clearly so that everyone is signed up to the same vision and purpose and understands what is being done to enable the network to deliver them.
  5. Start small: identify and work on a few priorities – ones agreed by practice members – so the benefit can be seen quickly.
  6. Given their fundamental roles as both forces for integration and in generating practice income, it’s worthwhile holding regular review meetings. They will give you space to identify and discuss which issues might block progress and to agree how to overcome them.
  7. Advertise the network’s successes and communicate them to members to establish buy-in and keep momentum.
  8. Don’t stand still: having moved swiftly to get started, your plans will need to evolve in response to new income opportunities as well as to changing local and national priorities. However, in considering new activities or contracts, ensure they are financially beneficial to the network and its members.
  9. Support your practices: explore with them the options for benefits such as shared staff, supporting challenged practices and delivering services together.
  10.  Look at building and maintaining longer term and wider relationships – ask how the network will work with other PCNs, local services and the community.

Establishing or redesigning PCNs will enable primary care leaders to emerge. Through working together they can give a stronger voice for primary care in integrated care systems and set a strong path for primary care to be the focus of health services for years to come.

In other words, it’s worth the effort to get them right.

Helen Northall is chief executive of PCC

Resources Primary/Community Services

Latest News

New code of conduct for AI systems

20 February 2019

The Department of Health and Social Care has issued a code of conduct for artificial intelligence (AI) and other data-driven technologies will ensure that only the best and safest systems are used by the NHS.

The code encourages technology companies to meet a gold-standard set of principles to protect patient data to the highest standards. It has been drawn up with the help of industry, academics and patient groups.

The aim is to make it easier for suppliers to develop technologies that tackle some of the biggest issues in healthcare, such as dementia, obesity and cancer. It will also help health and care providers choose safe, effective and secure technology to improve the services they provide.

Read More

More on GMS contract changes 2019/20

20 February 2019

NHS England has written to directors of primary care and senior CCG managers with further details of changes to the GMS contract for 2019/20. It includes notification of the one-off payment for indemnity inflation, changes to the value of QOF, global sum and out-of-hours payments, and the £1.761 per weighted patient for signing up to the forthcoming network contract directed enhanced service (DES).

Read More

Tobacco control assessment tools

19 February 2019

Self-assessment tools from Public Health England help local public health bodies to scrutinise their tobacco control work.

Read More

EU advice notice on falsified medicines directive

19 February 2019

The Safety Features Delegated Regulation, part of the EU Falsified Medicines Directive (FMD), will apply in the UK from 9 February 2019. Healthcare institutions are required to verify and decommission medicines supplied or administered directly to patients. All GP practices “personally administer” some medications and the decommissioning of these elements are covered by the GPIT operating model arrangements and centrally funded. According to the Medicines and Healthcare products Regulatory Agency (MHRA) FMD requirements would need to removed from law in the event of a no deal EU exit as we would no longer have access to the EU system. FMD preparations need to continue “with appropriate caution” given the possibility of a no deal scenario, the MHRA says.

Read More

NICE draft guidance recommends pertuzumab for early treatment of breast cancer

19 February 2019

NICE has published guidance recommending pertuzumab (Perjeta, Roche) for treating early HER2-positive breast cancer in people whose disease has spread to their lymph nodes.

Read More